Autonomic Drugs PNLE Questions
Introduction
The live published-question count for Autonomic Drugs is 10. The inventory was last updated August 12, 2026. These are original PNLE-style practice questions for identifying a drug class, linking receptor effects to patient findings, and choosing the safest nursing action.
The canonical scope includes cholinergic, anticholinergic, adrenergic, and antiadrenergic medications. Practice decisions include recognizing expected and dangerous effects, checking airway and circulation, interpreting contraindication cues, separating a medication’s purpose from its adverse effects, and prioritizing reassessment. Psychiatric and substance-use medications belong in Psychotropic & Addiction Drugs, outside this lens.
Under the 2025 Enhanced TOS, Autonomic Drugs is a Tangerine pedagogical lens mapped across relevant competencies in the official five-subject PNLE TOS. It belongs to NP7 Pharmacology as a cross-cutting practice area rather than a separate official test subject. The TOS provides broad competency relationships; it does not assign a microtopic weight or guarantee a particular number of Autonomic Drugs questions on an exam form.
Key concepts
- Start with the receptor action
Recognize: A class label becomes clinically useful when paired with its autonomic effect. Cholinergic activity generally increases parasympathetic-type effects, while adrenergic activity generally increases sympathetic-type effects, with the response shaped by receptor selectivity, dose, route, and patient condition.
Decide: Link the medication to expected changes in heart rate, blood pressure, secretions, bronchial tone, bowel activity, bladder activity, or pupil findings before selecting an answer.
Avoid: Choosing by a familiar drug name or one isolated vital sign without checking the full receptor pattern. - Recognize cholinergic excess early
Recognize: Cholinergic medications can increase secretions, gastrointestinal and bladder activity, bronchial secretions, and parasympathetic cardiac effects. Organophosphate poisoning involves acetylcholinesterase inhibition, causing excess acetylcholine at muscarinic and nicotinic sites.
Decide: Prioritize airway, breathing, breath sounds, secretions, oxygenation, and circulation when severe cholinergic findings appear. Activate emergency support and follow the prescribed poisoning protocol.
Avoid: Treating profuse secretions, bronchospasm, bradycardia, or weakness as an isolated minor adverse effect. - Interpret anticholinergic effects as a pattern
Recognize: Anticholinergic or antimuscarinic medications can reduce secretions and bowel or bladder activity while causing dry mouth, blurred vision, tachycardia, and urinary retention. Atropine belongs to this classification.
Decide: Assess oral secretions, heart rate, bowel and bladder function, vision complaints, mental status, and safety with ambulation or swallowing.
Avoid: Calling every dry mouth finding harmless when urinary retention, acute visual symptoms, confusion, or marked tachycardia is also present. - Match adrenergic effects to receptor clues
Recognize: Alpha-1 stimulation promotes vasoconstriction and increased vascular tone. Beta-1 stimulation affects heart rate and contractility, while beta-2 stimulation can promote bronchodilation and vasodilation in certain vascular beds.
Decide: Identify the receptor target, then monitor the response most relevant to the ordered medication, including blood pressure, pulse, rhythm, perfusion, and respiratory status.
Avoid: Assuming that every adrenergic medication produces the same cardiovascular or respiratory response. - Screen antiadrenergic therapy before administration
Recognize: Antiadrenergic medications reduce selected sympathetic effects, but their risks depend on the receptor target and patient condition. Beta blockade can reduce cardiac stimulation and may worsen bronchospasm, particularly when nonselective effects are involved.
Decide: Review the patient’s pulse, blood pressure, rhythm, airway history, perfusion, and prescribed hold parameters before giving the medication.
Avoid: Treating the class label as permission to administer without checking current assessment data and the specific order. - Explain unopposed alpha stimulation
Recognize: When beta-mediated vasodilation is blocked while alpha-mediated vasoconstriction remains active, vascular resistance can rise. The concept depends on receptor balance and the clinical context.
Decide: Evaluate blood pressure together with perfusion, chest symptoms, pulse, and the medication sequence or combination presented in the question.
Avoid: Labeling any blood-pressure increase as unopposed alpha stimulation without identifying the competing alpha and beta effects. - Use route and age cues for nasal adrenergic medications
Recognize: A topical nasal adrenergic medication can cause local vasoconstriction, while excessive or repeated use can worsen congestion. Topical administration does not remove the need to consider systemic cardiovascular effects.
Decide: Check the patient’s age, product instructions, route, dose, use pattern, nasal findings, blood pressure, and pulse before teaching or administering.
Avoid: Assuming that an adolescent or a nasal route automatically makes the medication risk-free.
What to expect on the PNLE
The inventory supports questions that ask learners to identify a classification or characterize a medication, explain a mechanism, match a purpose with a patient situation, recognize side effects, screen contraindication cues, or determine a preoperative effect. Mechanism-based items can connect acetylcholinesterase inhibition with cholinergic excess, while receptor-based items can compare alpha and beta effects or interpret a blocker combination.
The live difficulty distribution is 4 easy, 4 medium, and 2 hard. The live Bloom distribution is 4 remembering, 1 understanding, 3 applying, and 2 analyzing, supporting retrieval of classes, explanation of mechanisms, selection of a nursing action, and analysis of competing clinical cues.
- Remembering: retrieve drug classifications, receptor associations, and characteristic effects.
- Applying: use pulse, blood pressure, airway findings, secretions, urinary status, or preoperative context to choose the safest action.
- Analyzing: weigh multiple findings and distinguish a primary medication effect from a dangerous complication.
Exact topic distribution varies by exam form. Use this inventory to strengthen decision patterns across the canonical scope, rather than to estimate the content of any specific form.
Study tips
- Begin with diagnostic practice. Answer the 10 Autonomic Drugs questions without notes. Tag each response as class, mechanism, expected effect, adverse effect, contraindication, purpose, or priority action, then mark whether the error came from recall, interpretation, or prioritization.
- Use focused retrieval for the weakest tags. Make this comparison diagram yourself: Class → receptor or transmission effect → expected patient cues → serious risk → nursing assessment → priority action. Complete separate lines for cholinergic, anticholinergic, adrenergic, and antiadrenergic medications, adding a line for topical nasal use and organophosphate toxicity when those cues are difficult.
- Review every rationale and error. For each missed or guessed item, write the decisive cue, the receptor explanation, why the correct action protects the patient, and why each distractor is less safe. Include the distinction between atropine’s classification and its clinical use.
- Retry with spacing. Reconstruct the diagram later the same day, during the next study session, and again after other pharmacology work. On each retry, cover the drug-class labels and retrieve the effects from the clinical cues.
- Finish with mixed timed practice. Combine autonomic items with the adjacent Cardiovascular & Renal Drugs, Respiratory & Allergy Drugs, and Neurologic & Analgesic Drugs topics. Afterward, review reasoning quality rather than only the score, especially when a medication effect overlaps with a disease finding.
Common mistakes to avoid
- Relying on the drug name instead of its target. Similar-sounding medications can produce different receptor effects. The correcting cue is the medication’s class, receptor or transmission site, route, and intended purpose.
- Reading one symptom in isolation. A change in pulse or blood pressure becomes more meaningful when paired with secretions, bronchospasm, bowel or bladder changes, perfusion, or mental status. Use the complete cluster to identify the medication pattern and urgency.
- Confusing an expected anticholinergic effect with a safe effect. Dry mouth may be expected, but inability to void, acute visual symptoms, confusion, or marked tachycardia requires focused assessment and prompt reporting according to the order and protocol.
- Missing the airway priority in cholinergic excess. Excess secretions, wheezing, bronchospasm, bradycardia, and weakness can threaten ventilation. The safety principle is to assess airway and breathing before completing lower-priority teaching or documentation.
- Applying one contraindication to every adrenergic blocker. Screening must match the specific blocker and the patient’s pulse, blood pressure, rhythm, airway history, and perfusion. Use ordered parameters rather than an invented universal hold value.
- Assuming topical nasal use eliminates risk. Local administration still requires attention to age, product directions, repeated use, nasal response, and cardiovascular findings. Rebound congestion and systemic effects are cues to reassess teaching and medication use.
Try a question
A real Autonomic Drugs question from our bank. Give it a shot.
After phenylephrine eye drops, a patient’s pupil dilates but near focusing remains intact; blood pressure rises markedly. Which interpretation is best?
Phenylephrine is a selective alpha-1 adrenergic agonist commonly used as an eye drop for diagnostic mydriasis. Understanding its pharmacological profile is crucial for safe nursing practice.
Why Option C Is Correct
- Myriasis without cycloplegia: Phenylephrine stimulates the iris dilator muscle (alpha-1 receptors) causing the pupil to dilate, but does not block the accommodation (ciliary muscle function), so near focusing remains intact. Cycloplegia only occurs with anticholinergic agents (e.g., atropine or tropicamide), which paralyze accommodation by blocking muscarinic receptors.
- Concerning hypertension: Phenylephrine can be absorbed systemically, leading to vasoconstriction and a notable rise in blood pressure, especially in vulnerable populations. This adverse effect is clinically significant and requires careful monitoring, as it can precipitate hypertensive crises or other cardiovascular complications.
Why the Other Options Are Incorrect
| Option | Why Incorrect |
|---|---|
| A | "Associated cycloplegia" is wrong because phenylephrine does not cause cycloplegia; only mydriasis. Hypertension is correct here, but the inclusion of cycloplegia renders the answer inaccurate. |
| B | Cycloplegia is not expected with phenylephrine; this is seen with anticholinergics. "No important systemic reaction" is misleading, marked hypertension is an important systemic reaction and should never be dismissed. |
| D | Although systemic effects can occur, these are not "expected" when using topical agents and should never be considered routine. Routine BP observation is inadequate; hypertension warrants prompt intervention and safety measures. |
Clinical Pearl
- Memory Aid: "Phenylephrine = Pupil dilates, Pressure rises, but focusing preserved!" (Myriasis, hypertension, NO cycloplegia.)
Evidence-Based Practice
Udan's Nursing Review Book (Green Book) underscores the importance of monitoring for systemic adverse reactions even for topical medications. The standard of care is prompt assessment and reporting of abnormal vital signs, not routine or passive observation.
This question tests the student's ability to apply pharmacological knowledge with clinical reasoning, recognizing both expected drug actions and identifying when adverse effects require escalation.
DailyMed. (n.d.). Phenylephrine Hydrochloride Ophthalmic Solution. https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=phenylephrine+ophthalmic
Hinkle, Janice L., Cheever, Kerry H., & Overbaugh, Kristen J. (2022). Brunner & Suddarth's Textbook of Medical-Surgical Nursing (15th ed.). Wolters Kluwer. https://shop.lww.com/Brunner---Suddarth-s-Textbook-of-Medical-Surgical-Nursing/p/9781975161033
More Autonomic Drugs questions
9 questions available. Sign up to practice all of them.
A patient with suspected pheochromocytoma receives a beta blocker before adequate alpha blockade and develops severe hypertension. Which mechanism best explains the deterioration?
A nurse is caring for a patient who is mechanically ventilated and has been prescribed pancuronium bromide. What is the main therapeutic effect of this medication in this context?
A nurse is caring for a 13-year-old patient who has been prescribed Phenylephrine (Neo-Synephrine) nasal spray. The nurse explains the importance of using the nasal spray exactly as directed. What potential adverse effect should the nurse explain to the patient could occur if the nasal spray is overused?
References and further reading
- PRC Enhanced Table of Specifications for the Nurses Licensure Examination official
The current public competency and cognitive-level blueprint, effective from the November 2025 NLE onward. - Tangerine Prep PNLE Reviewer question bank
The live source for the published question count, question previews, rationales, and inventory distributions on this page.
How this page is built
The counts and distributions on this page come from Tangerine Prep's live published question bank. The source inventory was last updated on August 12, 2026.
The questions are original PNLE-style practice items, not recalled or leaked board questions. Topic scope follows Tangerine's pedagogical taxonomy and is mapped to the PRC 2025 Enhanced Table of Specifications, effective from the November 2025 NLE onward. Exact topic distribution varies by exam form.